{"id":"W4404637171","doi":"10.1158/1078-0432.ccr-24-0841","title":"Phase Ib Pharmacodynamic Study of the MNK Inhibitor Tomivosertib (eFT508) Combined With Paclitaxel in Patients With Refractory Metastatic Breast Cancer","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen's University; McGill University; University of British Columbia; Canada's Michael Smith Genome Sciences Centre; University of British Columbia Hospital; University of Alberta; Ontario Institute for Cancer Research; BC Cancer Agency; Jewish General Hospital","funders":"Canadian Institutes of Health Research; Stand Up To Cancer Canada","keywords":"Paclitaxel; Medicine; Breast cancer; Metastatic breast cancer; Pharmacodynamics; Cancer; Pharmacokinetics; Pharmacology; Clinical trial; Refractory (planetary science); Oncology; Internal medicine; Cancer research; Biology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006639507,0.001035867,0.001534696,0.0004184198,0.0003971624,0.0008475028,0.0006092069,0.001007115,0.002426398],"category_scores_gemma":[0.0006339861,0.0004599695,0.0007300579,0.0004426128,0.0006269484,0.0006523898,0.0002223805,0.002339676,0.0006653481],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001285702,"about_ca_system_score_gemma":0.001237769,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001024252,"about_ca_topic_score_gemma":0.002651321,"domain_scores_codex":[0.9997128,0.0001129595,0.00001675426,0.00004865403,0.00003475873,0.00007395838],"domain_scores_gemma":[0.9997229,0.00003224934,0.00006960126,0.00003068409,0.00002334979,0.0001211385],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4838365,0.1248423,0.01101572,0.0008937787,0.001413322,0.000467125,0.0003263737,0.006755774,0.2007633,0.0004703323,0.00523761,0.1639777],"study_design_scores_gemma":[0.2655886,0.6703482,0.0227121,0.00005380458,0.0006103915,0.0009361326,0.0001161525,0.003573704,0.03094908,0.00031613,0.004732339,0.00006337468],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9944945,0.001139266,0.0005332979,0.0003461757,0.00006656018,0.001382206,0.0006691329,0.00008733432,0.001281568],"genre_scores_gemma":[0.9943635,0.0006953579,0.001047002,0.000365739,0.00008181983,0.001174935,0.001100649,0.00002305388,0.001147906],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002426398,"threshold_uncertainty_score":0.009328485,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0711306112331,"score_gpt":0.4781960152094174,"score_spread":0.4070654039763174,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}